Bausch Health Companies

Phone: +15147446792

Fax: +1 (514) 744-6272

Web: https://www.bauschhealth.com

Type	Public
Traded as	TSX: BHC NYSE: BHC S&P/TSX 60 component
ISIN
Industry	Pharmaceuticals
Founded	1959 (1959) (as ICN Pharmaceuticals)
Founder	Milan Panić
Headquarters	Laval, Quebec, Canada
Key people	Thomas J. Appio (CEO) John Paulson (Chairman) Thomas G. Vadaketh (Executive VP & CFO) John S. Barresi (Senior VP & Controller)
Revenue	US$8.43 billion (2021)
Operating income	US$450 million (2021)
Net income	US$−937 million (2021)
Total assets	US$29.20 billion (2021)
Total equity	US$−34 million (2021)
Number of employees	c. 19,600 (2021)
Subsidiaries	Bausch & Lomb Medicis Pharmaceutical OraPharma Salix Pharmaceuticals Solta Medical
Website	bauschhealth.com

Bausch Health is focused on improving people’s lives with our health care products. We are delivering on our commitments to patients, health care providers, other stakeholders and society, as we build an innovative company dedicated to advancing global health. We manufacture and market a broad range of branded and generic pharmaceuticals, over-the-counter (OTC) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetic devices) directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Each day, our products are used by up to 150 million people around the world.

For detailed contact information visit location pages below.